{
  "trial_id": "NCT04073953",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "G6PD deficient",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "otherwise normal healthy adults aged 18 to 65",
      "label": "met",
      "evidence": "unknown"
    }
  ],
  "exclusion": [
    {
      "criterion": "Known history of liver, kidney or hematological disease (other than G6PD deficiency)",
      "label": "not_met",
      "evidence": "unknown"
    },
    {
      "criterion": "Known history of cardiac disease, non-sinus rhythm arrhythmia or QT prolongation",
      "label": "not_met",
      "evidence": "unknown"
    },
    {
      "criterion": "Autoimmune disorders",
      "label": "not_met",
      "evidence": "unknown"
    },
    {
      "criterion": "Report of an active infection",
      "label": "not_met",
      "evidence": "unknown"
    },
    {
      "criterion": "Subject is pregnant or breast-feeding, or is expecting to conceive during the study.",
      "label": "met",
      "evidence": "quote"
    }
  ],
  "notes": "16-year-old girl with myasthenia gravis, class IIa. Positive anti-AChR antibody test and SFEMG. On acetylcholinesterase inhibitor treatment combined with immunosuppressants.",
  "_meta": {
    "topic_id": "72",
    "trial_id": "NCT04073953",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}